Description

5,6-Dihydro-5-Methyl-6-Oxo-4H-Imidazo[1,5-A]Thieno[2,3-F][1,4]Diazepine-3-Carboxylic Acid 1,1-Dimethylethyl Ester is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for the synthesis of novel therapeutic agents, particularly in the central nervous system (CNS) drug discovery pipeline. It is primarily sought by research institutions and pharmaceutical manufacturers engaged in developing next-generation anxiolytics, sedatives, and other neuroactive compounds.

Application

• Key Intermediate in CNS Drug Synthesis: Serves as a crucial building block for the research and development of novel benzodiazepine analog pharmaceuticals.
• Preclinical & Clinical Research: Used in academic and industrial laboratories for pharmacological studies and the preparation of candidate drug molecules.
• Process Chemistry & Scale-Up: Employed in optimizing synthetic routes and scaling up production for active pharmaceutical ingredients (APIs).
• Reference Standard: Provides a high-purity standard for analytical method development, quality control, and regulatory submissions.
• Custom Synthesis & Contract Manufacturing: A starting material for the custom synthesis of specialized derivatives and analogs for targeted research programs.

Basic Information

Product Name	5,6-Dihydro-5-Methyl-6-Oxo-4H-Imidazo[1,5-A]Thieno[2,3-F][1,4]Diazepine-3-Carboxylic Acid 1,1-Dimethylethyl Ester
CAS No.	99632-94-7
Molecular Formula	C16H17N3O3S
Molecular Weight	331.39 g/mol
Synonyms	tert-Butyl 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate; 5,6-Dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylic acid tert-butyl ester; Imidazothienodiazepine derivative; TB-IMT; 99632-94-7
EINECS	Contact for details

Quality Control

Every batch of this pharmaceutical intermediate is produced under strict quality management systems. We provide comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles, ensuring traceability and compliance with cGMP standards where applicable. Our quality protocols are designed to meet the rigorous demands of pharmaceutical R&D and manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which may affect stability and handling properties.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0% Any single impurity ≤0.5%
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.